| Dr Lynette Liccini Luria, MD | |
|
Raf Lakenheath 48 Mdg/sghc, Unit 5115, Apo, AE 09461-5115 | |
| (163) 852-8124 | |
| Not Available |
| Full Name | Dr Lynette Liccini Luria |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | Raf Lakenheath 48 Mdg/sghc, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013328145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 125787 (Florida) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 125787 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lynette Liccini Luria, MD Raf Lakenheath 48 Mdg/sghc, Unit 5115, Apo, AE 09461-5115 Ph: (163) 852-8124 | Dr Lynette Liccini Luria, MD Raf Lakenheath 48 Mdg/sghc, Unit 5115, Apo, AE 09461-5115 Ph: (163) 852-8124 |
News Archive
Emergent BioSolutions today announced that its facility in Lansing, Michigan has been recognized with the 2013 North American Maintenance Excellence Award by the Foundation for Industrial Maintenance Excellence.
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday announced it will "integrate" the Affordable Medicines Facility-malaria (AMFm), implemented in 2010 as a pilot program to provide low-cost artemisinin-based combination therapies (ACTs) in poor and rural areas, "into its existing core system of providing grants to countries to purchase drugs, bed nets and other malaria-control measures," Nature News Blog reports.
With the use of a highly sensitive test, detection of the blood biomarker cardiac troponin T, a cardiac-specific protein, is associated with structural heart disease and an increased risk of all-cause death, according to a study in the December 8 issue of JAMA.
Genzyme Corp. today announced that its Board of Directors has voted to pursue several actions to increase shareholder value. The company will initiate a $2 billion stock buyback, under which $1 billion of stock will be repurchased in the near term and financed with debt. The additional $1 billion of stock will be repurchased during the next 12 months.
The study, to be published in the May/June edition of Women's Health Issues, investigated gender differences in cardiovascular disease prevention, treatment and risk factors based on national health care quality data from commercial and Medicare managed care plans.
› Verified 5 days ago
Dr. George Thomas Leonard Jr., M.D., PH.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-7868 | |
Luisa Y A Watts, M.D. Pathology Medicare: Medicare Enrolled Practice Location: Raf Lakenheath 48 Mdg/sghc, Unit 5115, Apo, AE 09461 Phone: 004-416-3852 | |
Dr. Tiffany Caye Levine, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-7889 | |
Dr. Erin Gorton, DO Pathology Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-7889 |